Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Outcomes of relapse after teclistamab therapy in multiple myeloma.
Journal: Blood cancer journal
Published: August 14, 2025
Understanding the impact of social determinants of health in hematology: a scoping review of trends across journals and over time.
Journal: Blood advances
Published: June 24, 2025
Understanding the impact of social determinants of health in hematology: a scoping review of trends across journals and over time.
Journal: Blood advances
Published: June 24, 2025
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review.
Journal: Journal for immunotherapy of cancer
Published: January 06, 2025
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.
Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma.
Journal: Hematology/oncology clinics of North America
Published: December 29, 2023
Bone marrow plasma cells require P2RX4 to sense extracellular ATP.
Journal: Nature
Published: February 14, 2023
Last Updated: 09/26/2026